A Jewel of a Resource From the Emerald Isle - - BioPharm International

ADVERTISEMENT

A Jewel of a Resource From the Emerald Isle

BioPharm International

The creation, dissemination, and exploitation of knowledge are the keys to unlocking the potential of Ireland's economy. Expertiseireland.com is a comprehensive research portal that provides a fast and effective gateway to the island's knowledge base. The portal offers a mechanism for identifying current research locations and support institutions for commercial and social capitalization. It presents in one searchable database up-to-date information on:



  • 3,900+ industry experts: research interests, projects, publications, conference history, patents, and consultancy background
  • Funding: viable funding sources on a local, national, and European level.
  • Technology transfer: innovative ideas produced in the third level sector available for capitalization

For added convenience, the portal also provides email alerts, which are triggered by changes to targeted expert profiles or funding opportunities, and current news that highlights issues relevant to R&D, education, finance, and capital investments.

Expertiseireland.com is directly populated from knowledge management systems originating at Ireland's academic institutions. The portal is designed primarily to help identify industry expertise and to serve as the contact point between those who create new ideas and those who implement them.

By providing a single access point, http://www.expertiseireland.com/ facilitates industry-academic collaborations and business-to-business alliances that utilize the world-class expertise and intellectual capital found on the island.

Expertiseireland.com is owned by the Irish Universities Association (Dublin, Ireland), formerly known as the Conference of Heads of Irish Universities. It is funded by InterTradeIreland. You may learn more about the association by visiting http://www.iua.ie/.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here